Invariant natural killer T cells treated with rapamycin or transforming growth factor-β acquire a regulatory function and suppress T effector lymphocytes

Ítems similars

• Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function
  per: Shin, Jinwook, et al.
  Publicat: (2014)
• Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome
  per: Rizzo, Chiara, et al.
  Publicat: (2019)
• Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation
  per: Dudreuilh, Caroline, et al.
  Publicat: (2021)
• KLRG(+) invariant natural killer T cells are long-lived effectors
  per: Shimizu, Kanako, et al.
  Publicat: (2014)
• Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
  per: Safinia, Niloufar, et al.
  Publicat: (2015)